3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
12
Prostatic Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Recurrence
4
Multiple Myeloma
4
Lymphoma, B-Cell
4
Lymphoma
4
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Cancer Pain
3
Urologic Neoplasms
2
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Kidney Neoplasms
2
Interventions
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Early Stage Triple Negative ER Low Breast Cancer
×
90 days
×
Clear all
NCT06710197
2026-03-05
OZM-034
University Health Network, Toronto
Phase 2
Withdrawn